Startup founders from Johns Hopkins aim to stop spread of cancer
July 28, 2021
AbMeta Therapeutics, launched by biologist and Provost Denis Wirtz, bioengineer Jamie Spangler, and clinician Elizabeth Jaffee, will combine years of pioneering research to create new drugs that target metastasis